Literature DB >> 32082766

The impact of pulmonary valve-sparing techniques on postoperative early and midterm results in tetralogy of Fallot repair.

Selim Aydın1, Dilek Suzan1, Bahar Temur1, Barış Kırat2, Müzeyyen İyigün2, İbrahim Halil Demir3, Ender Ödemiş3, Ersin Erek1.   

Abstract

BACKGROUND: In this study, we analyzed the impact of pulmonary valve-sparing techniques on early and midterm postoperative results of tetralogy of Fallot repair.
METHODS: A total of 64 patients diagnosed with tetralogy of Fallot, who underwent total correction operation by the same surgeon between November 2010 and September 2015 were included in this retrospective study. Mean age of the patients was 20.0±14.2 months (5.5-96 months). Forty patients (62.5%) were male. Thirty two of the patients (50%) were under one year of age. Pulmonary valve-sparing techniques were performed in 29 patients (Group 2), while transannular patch was applied in the remaining 35 patients (Group 1). Pericardial monocusp valve was constructed in 15 patients in Group 1. In Group 2, pulmonary valve-sparing techniques were transatrial repair in nine patients; transatrial-transpulmonary in eight, infundibular patch in eight, and infundibular-pulmonary patch in four patients.
RESULTS: There was no early postoperative mortality in Group 2. Five patients (14.2%) in Group 1 died in the early postoperative period (p=0.058). Pulmonary monocusp insertion was performed in 2 (13.3%) of these patients (p=1). The causes of mortality were sudden cardiac arrest (n=2), multiorgan failure (n=1), low cardiac output (n=1), and neurological complications (n=1). Five patients in Group 1 required extracorporeal membrane oxygenation support (ECMO). Three of them were separated from ECMO and two of the patients that were separated were discharged uneventfully. Total postoperative morbidity rate was significantly higher in Group 1 (51.4% vs. 6.8%) (p=0.0001). Morbidity rate was significantly lower in patients with pulmonary monocusp insertion than patients in the same group without a monocusp (p=0.0176). Forty nine (83%) of the patients were followed up for a median of 6.5 (1-24) months. While free pulmonary regurgitation was detected in all non-monocusp patients in Group 1, pulmonary regurgitation was absent or mild in Group 2. Twelve (80%) of the patients in Group 1 who had monocusp insertion were followed up. Only two of these patients had free pulmonary regurgitation (16.6%). The rest of them had mild (n=6) or mildmoderate pulmonary regurgitation (n=4).
CONCLUSION: Mortality and morbidity rates are lower when pulmonary valvesparing techniques are used in repair of tetralogy of Fallot. Monocusp pulmonary valve insertion may improve results in patients who require transannular patch repair. It is suggested that every effort should be made to achieve a competently working pulmonary valve during repair.
Copyright © 2018, Turkish Society of Cardiovascular Surgery.

Entities:  

Keywords:  Monocusp; pulmonary valve-sparing; tetralogy of Fallot; transannular patch

Year:  2018        PMID: 32082766      PMCID: PMC7018262          DOI: 10.5606/tgkdc.dergisi.2018.15499

Source DB:  PubMed          Journal:  Turk Gogus Kalp Damar Cerrahisi Derg        ISSN: 1301-5680            Impact factor:   0.332


  16 in total

1.  Tetralogy of Fallot: results of a pulmonary valve-sparing strategy.

Authors:  Robert D Stewart; Carl L Backer; Luciana Young; Constantine Mavroudis
Journal:  Ann Thorac Surg       Date:  2005-10       Impact factor: 4.330

2.  Long-term results after early primary repair of tetralogy of Fallot.

Authors:  E A Bacha; A M Scheule; D Zurakowski; L C Erickson; J Hung; P Lang; J E Mayer; P J del Nido; R A Jonas
Journal:  J Thorac Cardiovasc Surg       Date:  2001-07       Impact factor: 5.209

3.  Complete repair of tetralogy of Fallot in the neonate: results in the modern era.

Authors:  J C Hirsch; R S Mosca; E L Bove
Journal:  Ann Surg       Date:  2000-10       Impact factor: 12.969

4.  C. Walton Lillehei and total correction of tetralogy of Fallot.

Authors:  V L Gott
Journal:  Ann Thorac Surg       Date:  1990-02       Impact factor: 4.330

5.  Late survival and symptoms after repair of tetralogy of Fallot.

Authors:  N M Katz; E H Blackstone; J W Kirklin; A D Pacifico; L M Bargeron
Journal:  Circulation       Date:  1982-02       Impact factor: 29.690

6.  Long-term results of total repair of tetralogy of Fallot in childhood.

Authors:  P J Horneffer; K G Zahka; S A Rowe; T A Manolio; V L Gott; B A Reitz; T J Gardner
Journal:  Ann Thorac Surg       Date:  1990-08       Impact factor: 4.330

7.  Transatrial repair of tetralogy of Fallot.

Authors:  L H Edmunds; N C Saxena; S Friedman; W J Rashkind; P F Dodd
Journal:  Surgery       Date:  1976-12       Impact factor: 3.982

8.  Use of a pulmonary neovalve with a transannular patch for repair of tetralogy of fallot.

Authors:  Juan-Miguel Gil-Jaurena; Manuel Ferreiros; Rafael Castillo; Lourdes Conejo; Victorio Cuenca; Juan-Ignacio Zabala
Journal:  Rev Esp Cardiol       Date:  2010-12       Impact factor: 4.753

9.  Factors affecting perioperative mortality in tetralogy of Fallot.

Authors:  Murat Saygi; Yakup Ergul; Hasan Tahsin Tola; Isa Ozyilmaz; Erkut Ozturk; Ismihan Selen Onan; Sertac Haydin; Ersin Erek; Mehmet Yeniterzi; Alper Guzeltas; Ender Odemis; Ihsan Bakir
Journal:  Pediatr Int       Date:  2015-05-29       Impact factor: 1.524

10.  Right ventricular outflow tract reconstruction with a polytetrafluoroethylene monocusp valve: a twelve-year experience.

Authors:  John W Brown; Mark Ruzmetov; Palaniswamy Vijay; Mark D Rodefeld; Mark W Turrentine
Journal:  J Thorac Cardiovasc Surg       Date:  2007-03-19       Impact factor: 5.209

View more
  1 in total

1.  Transannular patch repair of tetralogy of Fallot with or without monocusp valve reconstruction: a meta-analysis.

Authors:  Xiaodong Wei; Tiange Li; Yunfei Ling; Zheng Chai; Zhongze Cao; Kerun Chen; Yongjun Qian
Journal:  BMC Surg       Date:  2022-01-16       Impact factor: 2.102

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.